Your support of Gabrielle’s Angel Foundation allows us to push the boundaries of what is scientifically possible for those living with blood cancer. Meet the dedicated research scientists whose cutting-edge ideas are giving patients reason to hope and hear all about their latest breakthroughs below!
Researchers at the University of North Carolina at Chapel Hill and the UNC Lineberger Comprehensive Cancer Center have uncovered a new role of a chromatin-modulatory enzyme, termed EZH2, during...
Congratulations to Gabrielle’s Angel Foundation grantee Dr. Shan Zha for being elected to the American Society for Clinical Investigation. “Shan’s work is simply inspiring and is...
Gabrielle’s Angels grantee Dr. Ari Melnick of Weill Cornell and his team have recently discovered that aggressive and relatively common lymphomas called diffuse large B cell lymphomas have a...
An immunotherapy harnessing the immune system’s “natural killer” cells has proven effective in treating acute myeloid leukemia (AML) in some adults whose cancers return. Now, researchers at...
Clockwise from top left: Andrew Intlekofer, MSKCC; Shannon Elf*, University of Chicago, Nathan Singh, Washington University St. Louis; Yibin Yang*, Fox Chase Cancer Center; Brian Dalton, Johns...
A new study from the lab of longtime Gabrielle’s Angel Foundation Medical Advisory Board member Dr. John DiPersio and Gabrielle’s Angels grantee Dr. Stephen Persaud has revealed a new...
Congratulations to Gabrielle’s Angels grantee Dr. Cigall Kadoch from Dana-Farber Cancer Institute for receiving the incredibly prestigious Howard Hughes Medical Institute (HHMI) Investigators...
The Mark Foundation for Cancer Research has partnered with the Gabrielle’s Angel Foundation for Cancer Research to fully support two of its Medical Research Awardees. The awardees, Dr. Shannon Elf...
Big news from the lab of former Gabrielle’s Angels grantee Dr. Scott Armstrong and his colleagues at Dana Farber! A new drug that not only could treat acute myeloid leukemia but also...
We love this feature on one of our fabulous grantees, Dr. Esther Obeng of St. Jude! Not only is Dr. Obeng a first-generation American, she’s also designing studies to identify cancer-causing...
Scientists have revealed how to modify CRISPR’s basic architecture to extend its reach beyond the genome and into the epigenome – proteins and small molecules that latch onto DNA and control when...
When researchers from Penn Medicine (including two of our grantees, Dr. Saar Gill and Dr. Marco Ruella!) found that many patients with B-cell acute lymphoblastic leukemia (ALL) treated with the...